SLC5A2 and type 2 diabetes mellitus: In a study performed by Ata et al. following patients with type 2 diabetes treated with SGLT-2 inhibitors, infection was the most common precipitating factor for both EDKA and classic hyperglycaemic DKA development, followed by insulin non-compliance, pancreatitis, and surgery.